RedHill Biopharma (RDHL) Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. AMC
4. WBD
5. MSFT
6. ACN
7. FFAI
8. PAA
9. TLT
10. PAGP

Go back to RedHill Biopharma (RDHL) Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19
REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.57 --0 (-0%)
Previous Close $0.57    52 Week High $16.54 
Open $0.57    52 Week Low $8.10 
Day High $0.57    P/E N/A 
Day Low $0.57    EPS $0.00 
Volume 1,646